Dr. Hope Rugo and advocate Jonise Louis discuss new ADCs, biomarker testing, and patient-centered dosing for metastatic triple-negative breast cancer. The treatment paradigm for metastatic ...
According to the American Lung Association, the national five-year lung cancer survival rate is about 29.7 percent. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results